OncoBeta

medical devices

About

OncoBeta® GmbH is a medical device and radiochemical company based in Garching near Munich, Germany. The company specializes in developing and commercializing innovative therapies for skin cancer, particularly non-melanoma skin cancers (NMSCs). Its primary product, Rhenium-SCT® (Skin Cancer Therapy), is a non-invasive treatment that uses rhenium-188 to deliver targeted radiation to skin cancer lesions in a single session, offering an alternative to traditional surgical methods. Founded with a mission to create advanced therapies for skin cancer, OncoBeta emphasizes regulatory compliance and safety in its operations. The company targets markets with high incidences of NMSC, such as Australia, and has established partnerships, including a collaboration with GenesisCare, to enhance access to its therapies. OncoBeta serves healthcare providers and clinics focused on dermatology and oncology, providing them with less invasive treatment options for their patients.

Technologies

Cloudflare DNS Outlook CloudFlare Hosting Google Tag Manager Mobile Friendly YouTube Google Maps Google Maps (Non Paid Users)

Keywords

nonmelanoma skin cancer treatment brachytherapy medical device rhenium basal cell carcinoma squamous cell carcinoma radioisotope epidermal radioisotope therapy skin cancer medical equipment manufacturing non-invasive skin cancer treatment high-energy beta emitter medical device for skin cancer radiochemical production high activity concentration medical devices oncology treatment regulatory approved skin cancer device treatment of squamous cell carcinoma medical equipment and supplies manufacturing rhenium-sct application system non-melanoma skin cancer therapy single treatment session oncology b2b radioisotope therapy epidermal radioisotope application dermatology oncology innovation low breakthrough radioisotope aesthetic outcomes

Location

91 Schleissheimer Strasse, Garching, Bavaria, Germany, 85748

Related Companies

Companies in the same industry